*Includes purchased research and development expenses of $96 million. Pro forma net income, excluding this nonrecurring item net of tax, would have been $512 million.

**Includes purchased research and development expenses of $508 million and realized gains on the sale of a minority stock investment of $152 million. Pro forma net income, excluding these nonrecurring items net of tax, would have been $1,416 million.

*** Includes purchased research and development expenses of $594 million and realized gain on the sale of a minority stock investment of $5 million. Pro forma net income, excluding these nonrecurring items net of tax, would have been $1,885 million.

**** Includes purchased research and development expenses of $471 million and acquisition-related costs of $16 million. Pro forma net income, excluding these nonrecurring items net of tax, would have been $2,548 million.

back to list
back to text